ConductScience.org, home

Paper39249113

Real-world outcomes of stage II and III colorectal cancers treated by postoperative adjuvant chemotherapy based on the mismatch repair status.

Iwata Y and 9 others. Surg Today, 2025. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. Real-world outcomes of stage II and III colorectal cancers treated by postoperative adjuvant chemotherapy based on the mismatch repair status. Papers, record 39249113. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39249113

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Real-world outcomes of stage II and III colorectal cancers treated by postoperative adjuvant chemotherapy based on the mismatch repair status.
PubMed
Journal
Surg Today
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
1.81, provisional
iCite
Revised in PubMed
2026-11-02
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Iwata YYoshinori
2Tanaka CChihiro
3Ohno SShinya
4Suetsugu TTomonari
5Tanaka HHideharu
6Watanabe TTaku
7Komori SShuji
8Nagao NNarutoshi
9Katayama MMasaki
10Kawai MMasahiko

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Colorectal NeoplasmsMajor topic
DNA Mismatch RepairMajor topic
Humans
Chemotherapy, Adjuvant
Female
Male
Neoplasm Staging
Middle Aged
Aged
Retrospective Studies
Treatment Outcome
Neoplasm Recurrence, Local
Adult
Survival Rate
Prognosis
Aged, 80 and over
Risk Factors
Proto-Oncogene Proteins B-raf

Source PubMed

Download CSV of topics

References38

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12732585412-Gene Recurrence Score Assay Stratifies the Recurrence Risk in Stage II/III Colon Cancer With Surgery Alone: The SUNRISE Study.J Clin Oncol2016https://conductscience.org/library/papers/27325854PubMed
227228287Effects of microsatellite instability on recurrence patterns and outcomes in colorectal cancers.Br J Cancer2016https://conductscience.org/library/papers/27228287PubMed
333264544Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer.N Engl J Med2020https://conductscience.org/library/papers/33264544PubMed
47826164Pathologic support for limited hepatectomy in the treatment of liver metastases from colorectal cancer.Ann Surg1995https://conductscience.org/library/papers/7826164PubMed
59563547Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome.Ann Surg1998https://conductscience.org/library/papers/9563547PubMed
623530978Repeat liver resection for recurrent colorectal metastases: a single-centre, 13-year experience.HPB (Oxford)2014https://conductscience.org/library/papers/23530978PubMed
723104709Risk factors for survival after lung metastasectomy in colorectal cancer patients: a systematic review and meta-analysis.Ann Surg Oncol2013https://conductscience.org/library/papers/23104709PubMed
829355075Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal Cancer.J Clin Oncol2018https://conductscience.org/library/papers/29355075PubMed
924859797A mutant BRAF V600E-specific immunohistochemical assay: correlation with molecular mutation status and clinical outcome in colorectal cancer.Target Oncol2015https://conductscience.org/library/papers/24859797PubMed
1033403729Real-world data on microsatellite instability status in various unresectable or metastatic solid tumors.Cancer Sci2021https://conductscience.org/library/papers/33403729PubMed
1131180819Prospective Multicenter Study on the Prognostic and Predictive Impact of Tumor Budding in Stage II Colon Cancer: Results From the SACURA Trial.J Clin Oncol2019https://conductscience.org/library/papers/31180819PubMed
1223045248Mutation profiling and microsatellite instability in stage II and III colon cancer: an assessment of their prognostic and oxaliplatin predictive value.Clin Cancer Res2012https://conductscience.org/library/papers/23045248PubMed
1322368298
Correlation of tumour BRAF mutations and MLH1 methylation with germline mismatch repair (MMR) gene mutation status: a literature review assessing utility of tumour features for MMR variant classification.
J Med Genet2012https://conductscience.org/library/papers/22368298PubMed
1425305506Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes.Gastroenterology2015https://conductscience.org/library/papers/25305506PubMed
1517660069Outcomes after resection of synchronous or metachronous hepatic and pulmonary colorectal metastases.J Am Coll Surg2007https://conductscience.org/library/papers/17660069PubMed
1619147861Microsatellite instability-low colorectal cancer acquires a KRAS mutation during the progression from Dukes' A to Dukes' B.Carcinogenesis2009https://conductscience.org/library/papers/19147861PubMed
1726226576American Gastroenterological Association Technical Review on the Diagnosis and Management of Lynch Syndrome.Gastroenterology2015https://conductscience.org/library/papers/26226576PubMed
1820498393Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer.J Clin Oncol2010https://conductscience.org/library/papers/20498393PubMed
1924120480Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial.Lancet Oncol2013https://conductscience.org/library/papers/24120480PubMed
2034542636KRAS and BRAF Mutations in Stage II and III Colon Cancer: A Systematic Review and Meta-Analysis.J Natl Cancer Inst2022https://conductscience.org/library/papers/34542636PubMed

See all 38 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
42125445Preoperative and Pathological Discrepancies in Colorectal Cancer: A Single-Institution Retrospective Analysis Based on Mismatch Repair/BRAF V600E Status.J Anus Rectum Colon2026https://conductscience.org/library/papers/42125445PubMed
42058534Robotic-assisted transverse colectomy for transverse colon cancer in a centenarian: a case report.J Surg Case Rep2026https://conductscience.org/library/papers/42058534PubMed
41987550Proteasome inhibitor, ixazomib prevents topoisomerase-I degradation and reverses irinotecan resistance in colorectal cancer.Mol Oncol2026https://conductscience.org/library/papers/41987550PubMed
40524028Impact of adjuvant chemotherapy on survival outcomes in older and non-older patients with high-risk stage II colorectal cancer.Surg Today2025https://conductscience.org/library/papers/40524028PubMed
39991497Spontaneous Regression of Advanced Transverse Colon Cancer: A Case Report.Surg Case Rep2025https://conductscience.org/library/papers/39991497PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
BRAF673PubTator's text mininghttps://conductscience.org/library/genes/673

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39249113

GET https://conductscience.org/api/papers/v1/39249113/references?page=2